Anti-PD-L1 and SAbR for Ovarian Cancer

Clinical trial NCT03312114 · TERMINATED

Trial details

NCT number: NCT03312114
Sponsor: University of Texas Southwestern Medical Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Epithelial Cancer of Ovary Primary Peritoneal Carcinoma Fallopian Tube Cancer

Start date: 2017-11-09
Primary completion: 2019-03-19
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.